These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38596000)

  • 1. Pulmonary Rehabilitation Associated with Noninvasive Ventilation on Physical Capacity and Quality of Life in Post-COVID-19: A Randomized Controlled Double-Blinded Clinical Trial Protocol.
    Arêas GPT; Goulart CDL; Sant'Anna T; Fernandes TG; Alvim RO; Borges FFDR; do Amaral CMSSB; Rodrigues SCF; Valente J; Ferreira JMBB; Rezende AG; de Oliveira Júnior EF; de Lacerda MVG; de Almeida-Val FF
    J Multidiscip Healthc; 2024; 17():1483-1490. PubMed ID: 38596000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Carvalho AC; Moreira J; Cubelo P; Cantista P; Branco CA; Guimarães B
    Trials; 2021 Apr; 22(1):268. PubMed ID: 33845878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).
    Ammous O; Feki W; Lotfi T; Khamis AM; Gosselink R; Rebai A; Kammoun S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD013778. PubMed ID: 36606682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of different modalities of inspiratory muscle training as an add-on to conventional treatment of patients with chronic obstructive pulmonary disease (COPD): study protocol for a randomized controlled trial.
    de Farias CAC; Gualdi LP; da Silva SB; Parreira VF; Montemezzo D; Resqueti VR; Fregonezi GAF
    Trials; 2019 Apr; 20(1):231. PubMed ID: 31014365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised, controlled, open-label pragmatic trial evaluating changes in functional exercise capacity after primary care
    Volckaerts T; Vissers D; Burtin C; Van Meerbeeck X; de Soomer K; Oostveen E; Claes K; Roelant E; Verhaegen I; Thomeer M; Criel M; Quadflieg K; Cops D; Ruttens D; Lapperre TS
    BMJ Open; 2023 Jun; 13(6):e071098. PubMed ID: 37270195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Ventilation as an Important Adjunct to an Exercise Training Program in Subjects With Moderate to Severe COPD.
    Marrara KT; Di Lorenzo VAP; Jaenisch RB; Cabiddu R; de Oliveira Sato T; Mendes RG; Oliveira CR; Costa D; Borghi-Silva A
    Respir Care; 2018 Nov; 63(11):1388-1398. PubMed ID: 29945905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kangyi Qiangshen Gong exercise prescription for pulmonary function and quality of life in patients recovered from COVID-19: a study protocol for a randomized controlled trial.
    Guo G; Xu X; Yin WY; Zhang K; Hui JPM; Yee JHY; Heng BCQ; Qin Y; Yao F; Fang M
    Trials; 2022 Oct; 23(1):875. PubMed ID: 36242061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study): study protocol for a two-center randomized controlled trial.
    Haukeland-Parker S; Jervan Ø; Johannessen HH; Gleditsch J; Stavem K; Steine K; Spruit MA; Holst R; Tavoly M; Klok FA; Ghanima W
    Trials; 2021 Jan; 22(1):22. PubMed ID: 33407792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorder: Protocol for a Pilot and Feasibility Randomized Controlled Trial.
    Rozenberg D; Al Kaabi N; Camacho Perez E; Nourouzpour S; Lopez-Hernandez L; McGillis L; Goligher E; Reid WD; Chow CW; Ryan CM; Kumbhare D; Huszti E; Champagne K; Raj S; Mak S; Santa Mina D; Clarke H; Mittal N
    JMIR Res Protoc; 2023 Mar; 12():e44832. PubMed ID: 36939815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
    Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
    Trials; 2021 May; 22(1):342. PubMed ID: 34001174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pulmonary rehabilitation programme including either O
    Elmorshidy BES; Elkholy MGA; Elsaadany HM; Mansour YM; Sharshar RS; Bahr HM
    Can J Respir Ther; 2023; 59():45-51. PubMed ID: 36741305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary rehabilitation for interstitial lung disease.
    Dowman L; Hill CJ; May A; Holland AE
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD006322. PubMed ID: 34559419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a cardiopulmonary rehabilitation protocol on functional capacity, dyspnea, fatigue, and body composition in individuals with post-COVID-19 syndrome: A randomized controlled trial.
    Gomes Dos Santos EG; Vieira da Costa K; Cordeiro de Souza IT; Victor Dos Santos Felix J; Furtado Brandão CB; Michelle de Souza Fernandes V; Lugon Favero AB; Lucrécia de Aquino Gouveia M; Tavares de Lima D; Heriston de Morais Lima J; Pedrosa R; Alves de Oliveira VM; da Cruz Santos A; Gama TO; Guedes de Brito GE; Tenório de França EE
    Physiother Res Int; 2024 Apr; 29(2):e2086. PubMed ID: 38572991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.